Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 9—September 2005
Research

Variant Creutzfeldt-Jakob Disease Death, United States

Ermias D. Belay*Comments to Author , James J. Sejvar*, Wun-Ju Shieh*, Steven T. Wiersma†, Wen-Quan Zou‡, Pierluigi Gambetti‡, Stephen Hunter*, Ryan A. Maddox*, Landis Crockett†, Sherif R. Zaki*, and Lawrence B. Schonberger*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Florida Department of Health, Tallahassee, Florida, USA; ‡Case Western Reserve University, Cleveland, Ohio, USA

Main Article

Figure 1

Histopathologic changes in frontal cerebral cortex of the patient who died of variant Creutzfeldt-Jakob disease in the United States. Marked astroglial reaction is shown, occasionally with relatively large florid plaques surrounded by vacuoles (arrow in inset) (hematoxylin and eosin stain, original magnification ×40).

Figure 1. . Histopathologic changes in frontal cerebral cortex of the patient who died of variant Creutzfeldt-Jakob disease in the United States. Marked astroglial reaction is shown, occasionally with relatively large florid plaques surrounded by vacuoles (arrow in inset) (hematoxylin and eosin stain, original magnification ×40).

Main Article

Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external